Page last updated: 2024-10-30

leflunomide and Dysembryoma

leflunomide has been researched along with Dysembryoma in 1 studies

Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Teschner, S1
Burst, V1

Reviews

1 review available for leflunomide and Dysembryoma

ArticleYear
Leflunomide: a drug with a potential beyond rheumatology.
    Immunotherapy, 2010, Volume: 2, Issue:5

    Topics: Animals; Antirheumatic Agents; Biological Availability; Contraindications; Cytomegalovirus Infection

2010